Prof. Cho Byoung Chul shares his experience of using the Guardant360® test in his clinic
July 1, 2022
Hear from Prof. Cho Byoung Chul, Chief of the Lung Cancer Center in Yonsei Cancer Center in Seoul, South Korea as he shares his experience of using the Guardant360® test in his clinic. Prof. Cho describes how Guardant Health’s liquid biopsy test was useful in guiding treatment decisions for his patient with a rare genomic alteration as he enrolled the patient in a clinical trial at the center. Visit us at https://www.guardanthealthamea.com/resources/to find out more about the Guardant360® test and how it can help guide treatment decisions for patients with advanced stage cancer.